PF353 PATIENTS WITH SEVERE CHRONIC NEUTROPENIA SUBTYPES TREATED WITH BIOSIMILAR FILGRASTIM: A STUDY BY THE EUROPEAN BRANCH OF THE SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY

Authors :: R. Nakov
C. Zeidler
N. Mathieson
S. Gattu
M. Natek
S. Mellor-Heineke
Source :: HemaSphere. 3:128
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: medicine.medical_specialty
business.industry
Internal medicine
Medicine
Chronic neutropenia
Biosimilar
Hematology
Filgrastim
business
medicine.drug

Full Text Access

Tools